Description
A bioactive oxysterol; a major oxysterol component of oxidized LDL; produced by oxidation of cholesterol via ethanol-mediated lipid peroxidation or photodamage as well as oxidation of 7-dehydro cholesterol by CYP7A1; inhibits CYP7A1 (IC50 = ~1 μM); induces activation and chemotaxis of retinal microglia as well as polarization to a pro-inflammatory state; increases ocular levels of VEGF, IL-1β, and GRO/KC, macrophage infiltration, and neovascularization in rat eye; levels are increased in lipid deposits in a variety of chronic diseases,
Formal name: 3β-hydroxy-cholest-5-en-7-one
Synonyms: 7-oxo Cholesterol|SC-4722|Δ5-Cholesterol-3β-ol-7-one
Molecular weight: 400.6
CAS: 566-28-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Reactive O2/N2 Pathways||Research Area|Lipid Biochemistry|Sterol Lipids||Research Area|Neuroscience|Ophthalmology||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation